COVID-19 Could Offer Some DSCSA Enforcement Relief For Manufacturers
Executive Summary
As the US FDA focuses on COVID-19 pandemic-related activities, the time may be right to ask for an extension in complying with the DSCSA’s saleable returns verification deadline.